Quick Answer
Lions Mane Cognition Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis.
Key Takeaways
- 01Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. [World Molecular Imaging Congress 2022 (2023)]
- 02Similarly, the specific binding of [C]mG2P001 was also increased with more unlabeled mG2P001 in the incubation media. [World Molecular Imaging Congress 2022 (2023)]
- 03[18F]FSPG, a glutamate analogue containing an [18F]fluoropropyl group, is used to image expression of the cystine/glutamate (x) transporter, which is upregulated in a variety of tumors, including non-small cell lung cancer, breast cancer, and liver cancer and has been associated with poor outcomes (). [World Molecular Imaging Congress 2022 (2023)]
- 04Title: World Molecular Imaging Congress 2022 Date: September 28-October 1, 2022 Location: Miami, FL, USA Sponsorship: Publication of this supplement was sponsored by the World Molecular Imaging Society. [World Molecular Imaging Congress 2022 (2023)]
The current Migaku evidence database contains 2 reusable source documents for Lions Mane Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. [World Molecular Imaging Congress 2022 (2023); evidence level 4]
- Similarly, the specific binding of [C]mG2P001 was also increased with more unlabeled mG2P001 in the incubation media. [World Molecular Imaging Congress 2022 (2023); evidence level 4]
- [18F]FSPG, a glutamate analogue containing an [18F]fluoropropyl group, is used to image expression of the cystine/glutamate (x) transporter, which is upregulated in a variety of tumors, including non-small cell lung cancer, breast cancer, and liver cancer and has been associated with poor outcomes (). [World Molecular Imaging Congress 2022 (2023); evidence level 4]
- Title: World Molecular Imaging Congress 2022 Date: September 28-October 1, 2022 Location: Miami, FL, USA Sponsorship: Publication of this supplement was sponsored by the World Molecular Imaging Society. [World Molecular Imaging Congress 2022 (2023); evidence level 4]
- 53 <sup>rd</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : Lisbon, Portugal, 11 - 15 September 2017. [53 <sup>rd</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : Lisbon, Portugal, 11 - 15 September 2017. (2017); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources